England NHS approves life-extending breast cancer drug for incurable patients

England's NHS has approved a new drug that extends life for patients with incurable breast cancer, marking a significant access expansion. The decision follows regulatory and cost-effectiveness reviews, though specific drug name and survival benefit details are not provided. This improves treatment options for a previously underserved patient group.